Literature DB >> 3162377

Alveolar hydatid cyst induced amyloid enhancing factor (AEF): physicochemical properties and abolition of AEF activity by serine protease inhibitors.

G V Abankwa1, Z Ali-Khan.   

Abstract

Cell free supernatants prepared from amyloidotic liver, unfractionated and fractionated peritoneal and spleen cells from casein stimulated (16 h post-injection) or alveolar hydatid cyst-infected (7 or 12 weeks post-infection, p. i.) C57BL/6J mice were used to assess amyloid enhancing factor (AEF) activity and to determine its cell-source and physicochemical properties. Of the various supernatants used, the plastic adherent spleen cell lysate (95% macrophages) from 7 weeks p.i mice showed greater AEF activity, on a cell to cell basis, than the lysates prepared from whole spleen cells, peritoneal exudate cells or nonadherent (96% lymphocytes) spleen cells. Culture supernatants obtained from Con A, LPS or the parasite antigen stimulated amyloidotic spleen cells but not the normal mouse spleen cells contained AEF activity; the supernatant from unstimulated amyloidotic spleen cells was negative for AEF activity. AEF was precipitated with 25% and 50% saturation with (NH4)2SO4 and after gel-filtration the low molecular weight fraction contained the AEF activity which on SDS-PAGE resolved into three peptides ranging between mol. wts 15,000 and 31,000. Of the various specific and nonspecific protease inhibitors tested, AEF activity was completely abolished by 30 min preincubation with 10 mM phenylmethylsulphonyl fluoride. Taken together, these results indicate that AEF may be a small molecular weight lysosomal neutral protease of neutrophil/macrophage origin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3162377      PMCID: PMC2013199     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  29 in total

1.  SULFONYL FLUORIDES AS INHIBITORS OF ESTERASES. 3. IDENTIFICATION OF SERINE AS THE SITE OF SULFONYLATION IN PHENYLMETHANESULFONYL ALPHA-CHYMOTRYPSIN.

Authors:  A M GOLD
Journal:  Biochemistry       Date:  1965-05       Impact factor: 3.162

2.  Inactivation of the protease inhibitor phenylmethylsulfonyl fluoride in buffers.

Authors:  G T James
Journal:  Anal Biochem       Date:  1978-06-01       Impact factor: 3.365

3.  Collagenase production by endotoxin-activated macrophages.

Authors:  L M Wahl; S M Wahl; S E Mergenhagen; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

4.  Amyloid-inducing factor and immunological unresponsiveness.

Authors:  E S Cathcart; O G Rodgers; A S Cohen
Journal:  Ann Rheum Dis       Date:  1972-07       Impact factor: 19.103

5.  Experimental murine amyloidosis in x-irradiated recipients of spleen homogenates or serum from sensitized donors.

Authors:  D T Janigan; R L Druet
Journal:  Am J Pathol       Date:  1968-02       Impact factor: 4.307

6.  The role of inflammatory cells in the pathogenesis of amyloidosis.

Authors:  R Kisilevsky; M Axelrad; W Corbett; S Brunet; F Scott
Journal:  Lab Invest       Date:  1977-12       Impact factor: 5.662

7.  Cellular changes in the lymphoreticular tissues of C57L/J mice infected with Echinococcus multilocularis cysts.

Authors:  Z Ali-Khan
Journal:  Immunology       Date:  1978-05       Impact factor: 7.397

8.  Degranulation of leukocytes in chronic granulomatous disease.

Authors:  R L Baehner; M J Karnovsky; M L Karnovsky
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

9.  Secretion of lysosomal hydrolases by stimulated and nonstimulated macrophages.

Authors:  J Schnyder; M Baggiolini
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

10.  Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes.

Authors:  G Lavie; D Zucker-Franklin; E C Franklin
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

View more
  6 in total

1.  Alzheimer's disease brain-derived ubiquitin has amyloid-enhancing factor activity: behavior of ubiquitin during accelerated amyloidogenesis.

Authors:  K Alizadeh-Khiavi; J Normand; S Chronopoulos; Z Ali-Khan
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Induction of amyloid enhancing factor and its biological properties in murine alveolar hydatidosis.

Authors:  G V Abankwa; Z Ali-Khan
Journal:  Br J Exp Pathol       Date:  1988-02

3.  Pathogenesis of secondary amyloidosis in an alveolar hydatid cyst-mouse model: histopathology and immuno/enzyme-histochemical analysis of splenic marginal zone cells during amyloidogenesis.

Authors:  T Du; Z Ali-Khan
Journal:  J Exp Pathol (Oxford)       Date:  1990-06

4.  Evidence for increased amyloid enhancing factor activity in Alzheimer brain extract.

Authors:  Z Ali-Khan; R Quirion; Y Robitaille; K Alizadeh-Khiavi; T Du
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

5.  The role of fibronectin in the development of experimental amyloidosis. Evidence of immunohistochemical codistribution and binding property with serum amyloid protein A.

Authors:  E Kawahara; M Shiroo; I Nakanishi; S Migita
Journal:  Am J Pathol       Date:  1989-06       Impact factor: 4.307

6.  Amyloid enhancing factor activity is associated with ubiquitin.

Authors:  K Alizadeh-Khiavi; J Normand; S Chronopoulos; A Ali; Z Ali-Khan
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.